Validation of diagnostic nomograms based on CE-MS urinary biomarkers to distinguish clinically significant prostate cancer
View ORCID ProfileMaria Frantzi, Isabel Heidegger, Marie C. Roesch, View ORCID ProfileEnrique Gomez-Gomez, Eberhard Steiner, View ORCID ProfileAntonia Vlahou, View ORCID ProfileWilliam Mullen, Ipek Guler, Axel S. Merseburger, View ORCID ProfileHarald Mischak, Zoran Culig
doi: https://doi.org/10.1101/2022.01.26.22269739
Maria Frantzi
1Department of Biomarker Research, Mosaiques Diagnostics, Hannover, Germany
Isabel Heidegger
2Department of Urology, Medical University of Innsbruck, Innsbruck, Austria
Marie C. Roesch
3University Hospital Schleswig-Holstein, Campus Lübeck, Department of Urology, Lübeck, Germany
Enrique Gomez-Gomez
4Urology Department, Reina Sofía University Hospital, Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), University of Cordoba (UCO), Cordoba, Spain
Eberhard Steiner
2Department of Urology, Medical University of Innsbruck, Innsbruck, Austria
Antonia Vlahou
5Systems Biology Center, Biomedical Research Foundation, Academy of Athens, Athens, Greece
William Mullen
6Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, United Kingdom
Ipek Guler
7Leuven Biostatistics and Statistical Bioinformatics Centre (L-BioStat), Katholiek Universiteit (KU) Leuven, University of Leuven, Leuven, Belgium
Axel S. Merseburger
3University Hospital Schleswig-Holstein, Campus Lübeck, Department of Urology, Lübeck, Germany
Harald Mischak
1Department of Biomarker Research, Mosaiques Diagnostics, Hannover, Germany
6Institute of Cardiovascular and Medical Science, University of Glasgow, Glasgow, United Kingdom
Zoran Culig
2Department of Urology, Medical University of Innsbruck, Innsbruck, Austria
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted January 28, 2022.
Validation of diagnostic nomograms based on CE-MS urinary biomarkers to distinguish clinically significant prostate cancer
Maria Frantzi, Isabel Heidegger, Marie C. Roesch, Enrique Gomez-Gomez, Eberhard Steiner, Antonia Vlahou, William Mullen, Ipek Guler, Axel S. Merseburger, Harald Mischak, Zoran Culig
medRxiv 2022.01.26.22269739; doi: https://doi.org/10.1101/2022.01.26.22269739
Validation of diagnostic nomograms based on CE-MS urinary biomarkers to distinguish clinically significant prostate cancer
Maria Frantzi, Isabel Heidegger, Marie C. Roesch, Enrique Gomez-Gomez, Eberhard Steiner, Antonia Vlahou, William Mullen, Ipek Guler, Axel S. Merseburger, Harald Mischak, Zoran Culig
medRxiv 2022.01.26.22269739; doi: https://doi.org/10.1101/2022.01.26.22269739
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2973)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12828)
- Forensic Medicine (12)
- Gastroenterology (834)
- Genetic and Genomic Medicine (4627)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2946)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4423)
- Nursing (238)
- Nutrition (653)
- Oncology (2299)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7014)
- Radiology and Imaging (1551)
- Respiratory Medicine (923)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (213)
- Urology (185)